Fresenius Medical Care (XTRA:FME) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, alongside positive ...
Fresenius Medical Care recently accelerated the second tranche of its €1.00 billion share buyback program, committing about €415 million to repurchases between January and May 2026 as part of its FME ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Fresenius Medical Care invests EUR 312 million and successfully closes a share purchase agreement with all non-physician investors in Interwell Health (IWH), accelerating the timeline originally set ...
Fresenius Medical Care FMS recently unveiled its forward-looking “FME Reignite” strategy at the 2025 Capital Markets Day, aiming to achieve industry-leading profitability while optimizing capital ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...